ADMS

Adamas Pharmaceutical Inc.

NASDAQ

Add Alert

ADMS

Adamas Pharmaceutical Inc.

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

conix

10/11/21 5:08 PM

Post #118

Re: #117: @wesley_ - $6.10 nice

ADMS Chart

wesley_

04/28/21 9:50 AM

Post #117

$6.10 nice

slow_feet

02/04/21 11:30 AM

Post #116

Perhaps the "analysts" and their friends have loaded up now. I'm expecting them to issue their new expert estimates soon:

https://www.marketwatch.com/investing/stock/adms/analystestimates?mod=mw_quote_tab

mm107

02/01/21 4:47 PM

Post #115

Re: #114: @peterus - approval and only %30 up with low

i got caught up in those Halts. Chased only to see it get sold down.

such good news, doesnt really make sense

peterus

02/01/21 2:47 PM

Post #114

Re: #113: @slow_feet - I bid for Feb and Mar 7.5 calls

approval and only %30 up
with low ss ?

slow_feet

02/01/21 2:45 PM

Post #113

Re: #112: @peterus - whats your pt here ?

I bid for Feb and Mar 7.5 calls for 3 straight weeks in mid-January since I wanted as little time-value as possible. My average % gain is ~4300%. I closed ~19% of my calls last Friday to get my initial outlay back, since the news could have been neutral/bad, and released pre/post market.

peterus

02/01/21 2:39 PM

Post #112

Re: #111: @slow_feet - investorshub.advfn.com/uimage/uploads/2021/1/22/ejzuxback_on.gif

whats your pt here ?

slow_feet

02/01/21 2:26 PM

Post #111

slow_feet

02/01/21 2:26 PM

Post #110

Adamas Announces FDA Approval for Second Indication for GOCOVRI(R)

slow_feet

02/01/21 1:01 PM

Post #109

Trading Halt

02/01/2021 13:00:14 ADMS Adamas Pharmaceuticals, Inc Cm NASDAQ T1

T1 Halt - News Pending
Trading is halted pending the release of material news.

slow_feet

02/01/21 10:58 AM

Post #108

8-K: 2/1/21

Item 1.01 Entry Into a Material Definitive Agreement.

As previously disclosed, Adamas Pharma, LLC, a wholly-owned subsidiary of Adamas Pharmaceuticals, Inc. (the “Company”) is involved in a lawsuit against Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA), Inc. (collectively “Zydus”) in the United States District Court for the District of New Jersey alleging infringement of the Company’s patents by Zydus. On January 30, 2021, the Company entered into a definitive agreement (the “Definitive Agreement”) with Zydus pursuant to which the parties agreed to end the lawsuit and dismiss it without prejudice. Pursuant to the Definitive Agreement, the Company grants a license to make, use, sell, offer to sell and import a generic version of GOCOVRI® (amantadine) extended release capsules, effective as of March 4, 2030, or earlier in certain circumstances typical for such agreements. In addition, the Definitive Agreement contains provisions that may accelerate the license date, including if unit sales of GOCOVRI in the 12-month period ending July 31, 2025 or any subsequent 12-month period decline by a specified percentage below GOCOVRI unit sales in the year ended December 31, 2019.

The Definitive Agreement will be submitted to the U.S. Federal Trade Commission and the U.S. Department of Justice. The Company expects to file the Definitive Agreement as an exhibit to its Quarterly Report on Form 10-Q for the quarter ending March 31, 2021.

Zydus Pharmaceuticals

slow_feet

01/29/21 3:49 PM

Post #107

Letting go of a small % of my ADMS calls, into the close, to cover initial outlay.

Calls are popping in the microwave...

slow_feet

01/26/21 4:33 PM

Post #106

MM's straightening the books in AH:

slow_feet

01/25/21 11:49 AM

Post #105

ADMS: ~71% of ~29M OS held by insiders/funds. This implies only ~8M of the ~19M float is tradable, provided the funds hang on.

slow_feet

01/25/21 9:33 AM

Post #104

Looks like someone has noticed ADMS. Now just need pps over $7.50 for Feb. Calls...

slow_feet

01/13/21 9:30 AM

Post #103

(i) 2021-02-01
ADMS GOCOVRI (ADS-5102)
FDA Approval announced August 24, 2017. PDUFA date February 1, 2021 for sNDA to include treatment of OFF episodes in PD patients receiving levodopa.

(ii) revenue update

TFMG

08/12/20 8:52 PM

Post #102

$ADMS | #AdamasPharmaceuticals Upside Targets

Adamas Pharmaceuticals , Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

ClayTrader Free

08/07/20 3:56 PM

Post #101

* * $ADMS Video Chart 08-07-2020 * *

Link to Video - click here to watch the technical chart video

Tanis2476

04/08/20 6:58 PM

Post #100

Hey, remember when this was about to launch and the VP of Market Access, M. Masterson, was considered to be “the most innovative person in Market Access?” LOLOLOLOLOL

Tanis2476

03/04/20 7:59 AM

Post #99

Re: #98: @dinogreeves - Took a small position for 1000 shares on

Wow, nice swing and miss.

dinogreeves PremiumMember

02/11/20 5:15 PM

Post #98

Took a small position for 1000 shares on this, will likely hit $10 tomorrow plenty of cash on hand and news after hours.

ClayTrader Free

01/08/20 5:00 PM

Post #97

* * $ADMS Video Chart 01-08-2020 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

12/18/19 5:51 PM

Post #96

* * $ADMS Video Chart 12-18-2019 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

12/17/19 6:12 PM

Post #95

* * $ADMS Video Chart 12-17-2019 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

11/08/19 4:07 PM

Post #94

* * $ADMS Video Chart 11-08-19 * *

Link to Video - click here to watch the technical chart video

Tanis2476

10/22/19 8:42 AM

Post #93

Re: #87: @ADVFN_bioking - good stock

LOLOLOLOL!!!

At $130k a year, this extended release of an ages old drug prices itself out of any success.

Who the hell came up with the price?!? Hopefully the we’re terminated.

ADVFN_bioking Terminated

10/16/19 11:57 AM

Post #92

strong buy

ADVFN_bioking Terminated

10/16/19 9:56 AM

Post #91

load up before monster news hit the wire

ADVFN_bioking Terminated

10/15/19 8:23 PM

Post #90

Re: #89: @ADVFN_bioking - trading massive under cash

phase 3 results imminent

ADVFN_bioking Terminated

10/15/19 8:22 PM

Post #89

Re: #88: @ADVFN_bioking - news coming

trading massive under cash

ADVFN_bioking Terminated

10/15/19 8:22 PM

Post #88

Re: #87: @ADVFN_bioking - good stock

news coming

ADVFN_bioking Terminated

10/15/19 8:22 PM

Post #87

good stock

Tanis2476

10/15/19 9:36 AM

Post #86

This company continues to disappoint.

ClayTrader Free

10/04/19 6:07 PM

Post #85

* * $ADMS Video Chart 10-04-2019 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

09/30/19 6:00 PM

Post #84

* * $ADMS Video Chart 09-30-2019 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

09/20/19 5:43 PM

Post #83

* * $ADMS Video Chart 09-20-2019 * *

Link to Video - click here to watch the technical chart video

whytestocks Free

05/31/19 1:50 PM

Post #82

News: $ADMS ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, May 31, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or “the Company”) (NASDAQ: ADMS ) f...

Find out more https://marketwirenews.com/news-releases/ongoing-investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-adamas-pharmaceuticals-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-8278320.html

Tanis2476

04/18/19 9:27 AM

Post #81

Re: #79: @CK56 - Is anyone here??? Looks like a sign

This is a garbage company with garbage leadership and a garbage product. People are resigning daily. Failed experiment. Look for $5 soon. It’s been a great Puts play.

0210

03/13/19 8:54 PM

Post #80

Re: #79: @CK56 - Is anyone here??? Looks like a sign

very interesting. fundamentals + technicals. sitting on starter today.

CK56

02/13/19 6:18 PM

Post #79

Is anyone here??? Looks like a sign of life today, in AM anyway. When it moves it moves quickly due to the heavy ownership of tutes thereby little float available. We just need a couple of big boys to come in here. SP can easily go to $17 to 18 range where it should be right now. it has stepped down way too much. turn around seems to have begun.

Staypositive1 Free

04/24/18 3:12 PM

Post #78

Toying with a run into the close.

Staypositive1 Free

04/24/18 2:02 PM

Post #77

Getting ready for a run here.

RainyDayWriter Free

03/31/18 4:06 PM

Post #76

How may this affect ADMS?
https://finance.yahoo.com/news/acorda-files-parkinson-apos-drug-140002308.html

RainyDayWriter Free

03/20/18 6:33 PM

Post #75

Benefits of Gocovri in Parkinson's patients:
http://crweworld.com/article/news-provided-by-globenewswire/252730/adamas-announces-publication-of-data-supporting-the-benefits-of-gocovri-in-parkinsons-disease-patients-with-dyskinesia

Staypositive1 Free

03/01/18 10:14 AM

Post #74

Re: #72: @Dragonfly79 - Hells yea

Looks like a long waiting game.

Staypositive1 Free

02/12/18 5:24 PM

Post #73

Re: #72: @Dragonfly79 - Hells yea

How much do u like HGMT. Hearing calls for 15.

Dragonfly79 Free

02/08/18 1:46 PM

Post #72

Re: #71: @Staypositive1 - Looking good here compared to the rest of

Hells yea

Staypositive1 Free

02/08/18 1:45 PM

Post #71

Re: #69: @Dragonfly79 - I’m thinking soon. They just raised 85

Looking good here compared to the rest of the market.

Staypositive1 Free

01/30/18 1:54 PM

Post #70

Re: #69: @Dragonfly79 - I’m thinking soon. They just raised 85

Very quickly.

Dragonfly79 Free

01/29/18 11:37 PM

Post #69

Re: #68: @Staypositive1 - Should see $55 next week.

I’m thinking soon. They just raised 85 million in a day at 41.50

Older

Adamas Pharmaceutical Inc. (ADMS)

Followers	11	Posters	35
Posts (Today)	0	Posts (Total)	118
Created	12/24/14	Type	Free
Moderators

Market Cap $106 m -- Cash $169 M --Parkinson Drug marketed -- Phase 3 readout of MS walking trial imminen (this Quarter) -- Namzaric (alzheimer´s dementia ) starting to receive royalties in may 2020 from Allergan = MASSIVE UNDERPRICED low float gem if phase 3 outcome is positive stock likely exploding to $10++ . STRONG BUY

Adamas Pharma (ADMS)

Marktkap: $106 M
Cash: $169 M
Price: $3.83

Shares Out: 27.7 M

Presentation
http://ir.adamaspharma.com/static-files/882038bd-aa87-458c-83c1-bba24c90550e

"INROADS Phase 3 study of ADS-5102 (GOCOVRI) for walking impairment in patients with multiple sclerosis (MS) enrollment" completed, with topline results expected late Q4 2019

"The company is also poised to begin receiving royalty payments in the low to mid-teens millions on sales of dementia drug Namzaric beginning in May 2020. Allergan reported total sales of $93 million for the drug through the first nine months of 2018. In other words, the future looks promising for the punching bag named Adamas Pharmaceuticals."